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Winston Churchill is among the most significant political figures in British, European and 
world politics in the twentieth century. Best known for his leadership of Britain in World War 
two, and for his extraordinary political and personal determination, Churchill faced some of  
his greatest challenges from the consequences of cerebral small vessel disease, between 1949 
and his death in 1965.  
 
In three articles in the Journal of the Royal Society of Medicine, Scadding and Vale provide 
clear and detailed accounts, taken from multiple contemporary sources, of Churchill’s strokes 
in 1949 and 1953, and other manifestations of cerebrovascular disease from 1950-1952. The 
articles elegantly remind us of the characteristic clinical features of ischaemic strokes due to 
cerebral small vessel disease (where occlusion of a small perforating artery typically causes a 
distinct “lacunar” clinical syndrome, most commonly a “pure motor stroke” with hemiparesis 
affecting the face, arm and leg) but also highlight important gaps in our current knowledge and 
treatments for this form of cerebrovascular disease. Small vessel occlusion accounts for about 
one in four ischaemic strokes;1 although the prognosis for recovery is generally good, a 
proportion of patients progress acutely in the first few days after onset, particularly in the 
domain of motor function.2 This notable clinical feature of small vessel strokes remains a 
clinical and research challenge today.  
 
Winston Churchill's behaviour and account at the time of onset of the first stroke in 1949 
suggest that the symptoms progressed over a matter of hours (first removing the ring, then 
mentioning a cramping feeling, then having writing difficulty). The progressive onset is typical 
of small vessel occlusion,2 and the clinical syndrome suggested involvement of the internal 
capsule and thalamus. The second stroke in 1953 also showed progressive and fluctuating onset 
in the first 24 hours, with the involvement of the face, arm and leg indicating a "pure motor 
stroke" due to a lesion in the corticospinal projections within the posterior limb of the internal 
capsule. This characteristic progression and fluctuation in the first day or so from the onset of 
small vessel occlusion are still not at all well understood. Suggested mechanisms include 
propagation of thrombosis, haemodynamic factors, excitotoxicity, inflammation, oedema, or 
conduction block. Some evidence suggests that patients with branch artery atherosclerotic 
disease affecting the parent artery (e.g. the proximal middle cerebral artery from which the 
lenticulostriate perforators arise) with proximal occlusion at a perforator origin are more likely 
to clinically progress than those with more distal occlusion of a perforating artery;3 this is 
hypothesised to result from either thrombus propagation along the perforator (with sequential 
progressive occlusion of lateral smaller branches) or reduction in perfusion (causing ischaemia 
spreading from the distal to proximal tissue irrigated by the perforating artery).  Some evidence 
from perfusion MRI supports a role for haemodynamic failure in progressive lacunar 
syndromes.4 Another hypothesis is that peri-infarct oedema might exert pressure on 
neighbouring perforating branches, causing them to occlude, thus extending the infarct.5  
 
These mechanisms are not just of academic interest, because they highlight the persisting gaps 
in our understanding and a lack of specific treatments. If thrombus propagation is important, 
then acute anticoagulation or thrombolysis might be reasonable in progressive small vessel 
stroke.  However, although intravenous thrombolysis is considered beneficial in all types of 
ischaemic stroke, there is limited evidence of specific efficacy in small vessel occlusion.6 
Endothelial dysfunction and platelet aggregation might logically respond to antiplatelet therapy 
while haemodynamic failure might require measures to improve perfusion therapy. Antiplatelet 
therapy with GP IIb/IIIa inhibitors (which can reduce thrombus growth and prevent 
reformation by competitive inhibition with fibrinogen) has shown some promise in small 
studies of progressive small vessel occlusion.7 Finally, although mechanical thrombectomy has 
revolutionised the treatment of ischaemic stroke due to large vessel occlusion in the anterior 
circulation, it is not feasible to apply this method to small vessel occlusion. Because there is 
still no specific treatment targeting small vessel occlusion, this is clearly an important topic for 
future clinical trials.   
 
These accounts of diagnosis made by careful clinical observation also remind us of the 
advances in brain imaging that underpin modern stroke diagnosis and treatment.   The authors 
describe accurate anatomical localisation based on careful clinical assessments, but a small 
haemorrhage could not be discounted entirely in either of these strokes, given Winston 
Churchill’s heavy alcohol intake and hypertension which, though associated with all stroke 
types, are the strongest risk factors for intracerebral haemorrhage. It is well known that a small 
deep haemorrhage can exactly mimic a classical lacunar syndrome. Even computed 
tomography – introduced in the 1980s - has limited sensitivity to detect small vessel occlusions 
(especially in the first hours), while MRI- introduced in the 1990s – is extremely sensitive to 
acute ischaemia within minutes of arterial occlusion.8 Recent advances in high field MRI now 
potentially allow visualisation of individual small vessels and occlusions, while blood-sensitive 
sequences can detect even small and chronic areas of bleeding, including cerebral 
microbleeds.9  
 
These accounts vividly show how occlusion of even tiny arteries can have profound personal 
and, in Winston Churchill’s case, political, implications. Although the first stroke in 1949 was 
minor and effectively concealed, seemingly not affecting his re-election in 1951, the 
subsequent consequences of small vessel disease undoubtedly had a profound impact on him. 
The transient attacks and cognitive disturbances occurring between 1950 and 1952 were clearly 
noted by Churchill and those that knew him, suggesting progressive neurological impairment, 
although he continued to function well in office. The later stroke of 1953 certainly endangered 
Churchill’s premiership and indeed the viability of his political career. It seems very likely that 
in addition to the generally favourable prognosis of strokes due to small vessel occlusion, 
Churchill’s unique determination and resilience were key factors in helping him to continue to 
function at the highest level within weeks of the stroke onset in 1953, despite the cumulative 
effects of cerebral small vessel disease over the preceding years.  
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